FIELD: ophthalmology. SUBSTANCE: method includes intravenous introduction in drops of normal human immunoglobulin in a dose of 25 ml diluted in 100 ml of 0.9-% sodium chloride solution. EFFECT: reduced frequency of complication occurrence, reduced terms of treatment. 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ENDOCRINE OPHTHALMOPATHY TREATMENT | 2020 |
|
RU2725861C1 |
METHOD FOR ENDOCRINE OPHTHALMOPATHY EARLIEST MANIFESTATIONS DIAGNOSING | 2016 |
|
RU2617198C1 |
SURGICAL METHOD FOR TREATING THE PATIENTS SUFFERING FROM ENDOCRINE OPHTHALMOPATHY IN DECOMPENSATION PERIOD AND ENDOCRINE MYOPATHY | 2001 |
|
RU2192823C1 |
METHOD FOR TREATING ENDOCRINE OPHTHALMOPATHY | 2022 |
|
RU2791648C1 |
METHOD OF SURGICAL TREATMENT OF ENDOCRINE OPHTHALMOPATHY | 2010 |
|
RU2420236C1 |
METHOD FOR EARLY DIAGNOSIS OF AN ACTIVE PHASE OF ENDOCRINE OPHTHALMOPATHY | 2018 |
|
RU2687082C1 |
METHOD OF COMBINED CONSERVATIVE TREATMENT OF ACTIVE ENDOCRINE OPHTHALMOPATHY | 2022 |
|
RU2806503C1 |
METHOD FOR INDIVIDUAL PRESCRIPTION OF SYSTEMIC GLUCOCORTICOSTEROID PULSE THERAPY IN PATIENTS WITH ENDOCRINAL OPHTHALMOPATHY | 2012 |
|
RU2503011C1 |
METHOD FOR TREATING ENDOCRINE OPHTHALMOPATHY OF LOW AND MODERATE SEVERITY IN CASES OF DIFFUSE TOXIC GOITER | 1995 |
|
RU2124348C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF ENDOCRINE OPHTHALMOPATHY | 2005 |
|
RU2283034C1 |
Authors
Dates
1999-05-10—Published
1996-02-28—Filed